Market Research Logo

Vaccines: The World Market

What are the trends that are fueling a new boom in vaccine production and sales? Why is an industry so commonly associated with children finding an increasing marketplace among adult populations? What makes this class of drugs likely to grow at a faster rate than other pharmaceutical products? These are among the questions answered in Kalorama’s in-depth report, Vaccines: The World Market.

With the historic success of vaccines in virtually eliminating diseases such as small pox and polio, and with their obvious benefit of preventing disease before it occurs, vaccines are a 9 billion dollar industry and new vaccines continue to be developed. Kalorama’s Vaccines: The World Market breaks down the market for pediatric and adult vaccines, providing background information, revenue numbers, and a discussion of critical trends that anyone seeking opportunities in vaccines will need to be aware of. Among the exhaustive information in this report, the following topics are discussed in detail:

  • Current and Forecasted Revenue Figures to 2012 for strategic planning and new product consideration.
  • Over 55 Tables and Figures for easy access to decision support information in proposals, internal memos and business plans.
  • Round-up of Key Vaccine Companies for benchmarking and marketplace knowledge.
  • Discussion of Major Issues and Trends such as vaccine safety and legislation affecting the market; current vaccine companies can use to plan, new entrants can use to quickly bring themselves up to speed on the marketplace and steer clear of problem areas.
  • Review of the Robust Vaccine Pipeline (nearly 200+ drugs in development) and how they are expected to affect the market, so that executives can adjust business decisions to the most likely market scenario.
Current revenues and revenue forecasts to 2012 are included for the following pediatric vaccine categories:
  • DTaP & DTP Vaccines
  • Hep Vaccines
  • HiB Vaccines
  • MMR Vaccines
  • Combination Vaccines
  • Pneumococcal Vaccines
  • Polio Vaccines
  • Varicella Vaccines
  • Other Pediatric Vaccines

As well as Revenues and Forecasts to 2012 for the following adult vaccine categories:

  • Influenza Vaccines
  • Hepatitis Vaccines
  • Pneumococcal Vaccines
  • Travel, DT and other Adult Vaccines

Additionally, this report provides current market size and forecasts the following cancer vaccines:

  • Breast Cancer
  • Cervical Cancer
  • Colon/Rectal Cancer
  • Lung
  • Melanoma
  • Prostate
  • Other cancers.

Kalorama’s trusted information-gathering process provides the most accurate study of the market for vaccines available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies. While financial reports, major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Sales, Marketing, Business Development and Strategic Planning executives in the pharmaceutical industry, advertising agencies and consulting groups who work with pharmaceutical clients as well as institutional librarians are among those who will benefit from Kalorama’s detailed analysis of the vaccine market.

As part of its detailed coverage, Kalorama’s Vaccines: The World Market features profiles of the following companies:

  • Acambis plc
  • AlphaVax, Inc.
  • Avant Immunotherapeutics
  • Bavarian Nordic A/S
  • Baxter Healthcare
  • Berna Biotech AG
  • Emergent Biosolutions
  • GlaxoSmithKline
  • MEDIMMUNE
  • Merck & Co. Inc
  • Nabi Biopharmaceuticals
  • Novartis
  • PFIZER
  • Pharmexa
  • SANOFI Pasteur
  • Vical
  • Wyeth


  • Executive Summary
    • THE GLOBAL VACCINES INDUSTRY
      • Scope And Methodology
      • Overview
      • Pediatric Preventative Vaccines
    • THE MARKET
      • Adult Preventative Vaccines
    • THE MARKET
    • TOTAL MARKET
    • EMERGING CANCER VACCINES
      • The Market
      • Issues and Trends
  • Introduction to Vaccines
    • Table Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2005
    • A BRIEF HISTORY: THE DEVELOPMENT OF VACCINES
    • THE IMMUNE RESPONSE
    • MECHANISM OF ACTION
    • TYPES OF VACCINES
      • Attenuated (Weakened) Live Viruses
        • Table Vaccine-Preventable Diseases
      • Killed (Inactivated) Viruses
      • Toxoid Vaccines
      • Genetically Engineered/Modified Vaccines
    • VACCINE APPROVAL PROCESS
  • Pediatric Preventive Vaccines
    • INTRODUCTION
      • Table Global Immunization Rates by Vaccine Type 2005
    • CHILDHOOD IMMUNIZATION IN THE UNITED STATES
      • Childhood Immunization Rates
        • Table Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1999-2005
      • Challenges to the Vaccine Delivery System
      • Recommended Childhood Immunization Schedule
    • PEDIATRIC VACCINE PRODUCTS
      • BCG Vaccines
      • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio Vaccines
      • Haemophilus Influenzae Type B Vaccines
      • Hepatitis A Vaccines
      • Measles, Mumps and Rubella Vaccines
      • Pneumococcal Conjugate Vaccine
      • Rotavirus Vaccines
      • Varicella Vaccines
    • COST OF VACCINES IN THE UNITED STATES
      • Table Cost of Vaccines: Private Sector Versus Public Sector Prices Last Reviewed/Updated, September 2006 (Vaccine, Brand Name, Packaging, CDC Cost/Dose, Private Sector Cost/Dose, Contract End Date, Manufacturer)
    • PEDIATRIC VACCINES IN DEVELOPMENT
      • Global Initiatives for Vaccine Research
      • Diarrhea-Related Diseases
        • Table Selected Pediatric Vaccines in Development (Company, Product Name, Indication, Development Status)
      • Acute Respiratory Infections
      • Other Conditions
    • THE WORLD MARKET FOR PEDIATRIC PREVENTIVE VACCINES
      • Total Market Size and Forecast
        • Table World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others) 2003-2012 Revenues (in millions)
        • Table Market Share of Pediatric Vaccines by Type 2005
        • Table Market Share of Pediatric Vaccines, by Type 2012
      • DTP and DTaP Vaccine Market
        • Table World DTP and DTaP Vaccine Market 2003-2012
      • Hepatitis Vaccine Market
        • Table World Pediatric Hepatitis Vaccine Market 2003-2012
      • Haemophilus Influenzae Type B Vaccine Market
        • Table World Hib Vaccine Market, 2003-2012
      • Measles, Mumps and Rubella Vaccines
        • Table World MMR Vaccines Market 2003-2012
      • Combination Vaccines Market
        • Table World Combination Vaccines Market 2003-2012
      • Pneumococcal Vaccine
        • Table World Pediatric Pneumococcal Vaccine Market 2003-2012
      • Poliovirus Vaccine
        • Table World Poliovirus Vaccine Market 2003-2012
      • Varicella Vaccines
        • Table World Varicella Vaccine Market 2003-2012
      • Other Vaccines Market
        • Table Other Vaccines Market 2003-2012
  • Adult Preventive Vaccines
    • INTRODUCTION
    • ADULT VACCINE-PREVENTABLE DISEASES: FACTS AND FIGURES
    • GLOBAL VIROLOGICAL SURVEILLANCE PROGRAM
    • RECOMMENDATIONS FOR ADULT IMMUNIZATIONS
      • Vaccine Recommendations for International Travel
      • CDC's Recommendations for Yellow Fever Vaccination
      • WHO International Health Regulations
    • ADULT VACCINE PRODUCTS
      • BCG Vaccines
      • Cholera Vaccines
      • Diphtheria-Tetanus Vaccines
      • Hepatitis Vaccines
      • Influenza Vaccines
      • Japanese Encephalitis Vaccine
      • Pneumococcal Disease Vaccines
      • Rabies Vaccine
      • Typhoid Vaccines
      • Yellow Fever Vaccines
    • ADULT VACCINES IN DEVELOPMENT
    • GLOBAL INITIATIVES FOR VACCINE RESEARCH
      • Cholera
        • Table Selected Adult Preventive Vaccines in Development, 2007 (Company, Product Name, Indication, Development Status)
      • Dengue Fever
      • Epstein-Barr Virus
      • HIV/AIDS
      • Helicobacter Pylori
      • Hepatitis
      • Herpesvirus
      • Leishmaniasis
      • Malaria
      • Severe Acute Respiratory Syndrome
      • Shigella
      • West Nile Virus
    • THE WORLD MARKET FOR ADULT PREVENTIVE VACCINES
      • Total Market Size and Forecast
        • Table World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2003-2012 Revenues (in millions)
        • Table Market Share of Adult Vaccines, by Type, 2005
        • Table Market Share of Adult Vaccines, by Type, 2012
      • Hepatitis Market
        • Table World Hepatitis Vaccine Market 2003-2012
      • Influenza Vaccine Market
        • Table World Influenza Vaccine Market 2003-2012
        • Table U.S. Influenza Vaccination Rates by Age and Risk Group 2004 - 2005
        • Table 2005 Estimated Population by Region and Selected Age Group Population (in millions)
        • Table World Pneumococcal Vaccine Market 2003-2012
      • Travel, DT, and Miscellaneous Vaccine Market
        • Table World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2003-2012
  • Preventive Vaccines Market Summary
    • TRENDS DRIVING THE PREVENTIVE VACCINES MARKET
    • MARKET SIZE AND FORECAST
      • Table The World Vaccines Market by Vaccine Type 2003-2012 Revenues (in millions)
      • Table World Market for Vaccines Share by Type, 2003, 2007 and 2012
      • Vaccine Market Competitors
        • Table Major Manufacturers' Shares of the World Vaccine Market, 2005
      • Pediatric Vaccines
        • Table Major Manufacturer's Shares of the World Pediatric Vaccine Market 2005
      • Adult Vaccines
        • Table Major Manufacturer's Shares of the World Adult Vaccine Market 2005
  • Emerging Cancer Vaccines
    • HISTORY AND GROWTH OF THE CANCER TREATMENT MARKET
    • CANCER VACCINE TECHNOLOGY
      • Antigen/Adjuvant Vaccines
      • Whole Cell Tumor Vaccines
      • Dendritic Cell (DC) Vaccines
      • Viral Vectors and DNA Vaccines
      • Idiotype Vaccines
      • Types of Therapeutic Vaccines
    • CANCER STATISTICS
      • Table Estimated and Projected World Cancer Incidence by Selected Types of Cancer (Lung, Breast, Colon/Rectum, Stomach, Liver, Prostate, Cervix, Esophogus, Lymphoma, Pancreas, Melanoma), 2005 and 2020 (in thousands)
      • Table Estimated and Projected World Cancer Mortality by Selected Types of Cancer (Lung, Breast, Colon/Rectum, Stomach, Liver, Prostate, Cervix, Esophogus, Lymphoma, Pancreas, Melanoma), 2005 and 2020(in thousands)
      • Table Total Cancer Incidence by Sex and Country, 2006 Estimates (in thousands)
    • AVAILABLE CANCER VACCINES
      • Bladder Cancer
        • Table Estimated Cancer Incidence by World Region and Type of Cancer Cancer Incidence by World Region (in thousands)
      • Cervical Cancer
      • Colorectal Cancer
      • Melanoma
        • Table Malignant Conditions of the Skin
    • TYPES OF CANCERS SUSCEPTIBLE TO VACCINES
      • Breast Cancer
      • Gastrointestinal Cancer
      • Kidney
      • Leukemia
      • Lung Cancer
        • Table Types of Primary Lung Cancer, Risk Factors, Percent of Cases
      • Lymphoma
      • Multiple Myeloma
      • Neuroblastoma
      • Ovarian Cancer
      • Prostate Cancer
      • Sarcoma
    • CANCER VACCINE PIPELINE
      • Table Selected Cancer Vaccines in the Pipeline (Product Name, Developer, Indication, Development Phase, Earliest Approval Date)
      • Colorectal Cancer
      • Lung Cancer
      • GV-1001
      • Lymphoma
      • Melanoma
      • Prostate Cancer
      • Other Cancers
      • Telomerase
    • THE EMERGING CANCER VACCINE MARKET
      • Total Market Size and Forecast
        • Table World Market Cancer Vaccines by Cancer Type (Cervical, Colon/Rectal, Lung, Melanoma, Prostate, Other) 2003-2012 (Revenues in millions)
        • Table Share of the Cancer Vaccine by Vaccine Indication, 2012
      • Competitor Analysis
  • Issues and Trends
    • VACCINE SAFETY
      • Pre-licensure Evaluation
      • Post-Licensure Surveillance
      • The Vaccine Injury Compensation Program
      • World Health Organization
      • Other Initiatives
      • The Future of Vaccine Safety
    • VACCINE SHORTAGES
      • Preventing Future Shortages in the U.S.
      • Addressing Shortages in Developing Nations
    • PREVENTING PANDEMICS
    • VACCINES AND BIOTERRORISM
      • Overview
      • Project Bioshield Act of 2004
        • Table Selected Companies/Laboratories Developing Biodefense Vaccines
      • National Bio and Agro-Defense Facility
      • Anthrax
      • Smallpox
      • Plague
      • Botulism
      • Tularemia
      • Viral Hemorrhagic Fevers
    • INNOVATIONS IN VACCINE DELIVERY SYSTEMS
      • Edible Vaccines
      • Mucosal Delivery
      • Intranasal Delivery
      • Oral Vaccines
      • Vaccine Patches
  • Company Profiles
    • ACAMBIS PLC
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • ALPHAVAX, INC.
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
    • AVANT IMMUNOTHERAPEUTICS
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BAVARIAN NORDIC A/S
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BAXTER HEALTHCARE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BERNA BIOTECH AG
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • EMERGENT BIOSOLUTIONS
      • History and Lines of Business
      • Strategic Acquisition and Alliance
      • Vaccine Products
      • Financial
    • GLAXOSMITHKLINE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • MEDIMMUNE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • MERCK & CO. INC
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • NABI BIOPHARMACEUTICALS
      • History and Lines of Business
      • Strategic Alliance
      • Vaccine Products
      • Financial Information
    • NOVARTIS
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • PFIZER
      • History and Lines of Business
      • Vaccine products
      • Financial Information
    • PHARMEXA
      • History and Lines of Business
      • Vaccine Products
      • Financial Information
    • SANOFI PASTEUR
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • VICAL
      • History and Lines of Business
      • Strategic Alliances
      • Technology Platform
      • Therapeutic Cancer Vaccine Products in Clinical Trials
      • Financial Information
    • WYETH
      • History and Lines of Business
      • Vaccine Products
      • Financial Information
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report